Published in Lancet on May 26, 2001
Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. JAMA (2001) 5.77
HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis (2006) 3.09
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials (2008) 2.35
Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children. Pediatr Infect Dis J (2004) 2.30
Does breastfeeding really affect mortality among HIV-1 infected women? Lancet (2001) 1.70
What can we do to reduce mother to child transmission of HIV? BMJ (2002) 1.63
Prolonged breast-feeding and mortality up to two years post-partum among HIV-positive women in Zambia. AIDS (2005) 1.36
Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up. J Acquir Immune Defic Syndr (2007) 1.35
Current knowledge and future research on infant feeding in the context of HIV: basic, clinical, behavioral, and programmatic perspectives. Adv Nutr (2011) 1.22
A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr (2012) 1.18
Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda. AIDS (2010) 1.12
HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS (2013) 1.02
CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. J Infect Dis (2001) 1.00
The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda. BMC Public Health (2013) 0.98
Social determinants of mixed feeding behavior among HIV-infected mothers in Jos, Nigeria. AIDS Care (2009) 0.96
Use of lipid-based nutrient supplements by HIV-infected Malawian women during lactation has no effect on infant growth from 0 to 24 weeks. J Nutr (2012) 0.93
Lactation-associated postpartum weight changes among HIV-infected women in Zambia. Int J Epidemiol (2010) 0.91
HIV: prevention of mother-to-child transmission. BMJ Clin Evid (2011) 0.91
HIV: mother-to-child transmission. BMJ Clin Evid (2008) 0.87
A qualitative investigation into knowledge, beliefs, and practices surrounding mastitis in sub-Saharan Africa: what implications for vertical transmission of HIV? BMC Public Health (2007) 0.86
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study. Antivir Ther (2014) 0.84
Regular review: HIV infection in children. BMJ (2001) 0.83
Perinatal Transmission of HIV: Recognition and Treatment Interventions. Curr Infect Dis Rep (2001) 0.80
Maternal HIV is associated with reduced growth in the first year of life among infants in the Eastern region of Ghana: the Research to Improve Infant Nutrition and Growth (RIING) Project. Matern Child Nutr (2012) 0.79
Effect of nutritional supplementation of breastfeeding HIV positive mothers on maternal and child health: findings from a randomized controlled clinical trial. BMC Public Health (2011) 0.79
Weight changes during and after 6 months of breastfeeding in HIV-infected mothers receiving antiretroviral therapy in Malawi. AIDS Res Hum Retroviruses (2014) 0.77
HIV status, breastfeeding modality at 5 months and postpartum maternal weight changes over 24 months in rural South Africa. Trop Med Int Health (2014) 0.77
Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women. J Acquir Immune Defic Syndr (2016) 0.76
Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. PLoS One (2014) 0.76
Re: HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis (2007) 0.75
Breastfeeding in HIV-1-positive mothers. Lancet (2001) 0.75
Breastfeeding in HIV-1-positive mothers. Lancet (2001) 0.75
Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children. Front Immunol (2016) 0.75
[HIV/AIDS and Breastfeeding.] Rev Chil Nutr (2006) 0.75
Breastfeeding in HIV-1-positive mothers. Lancet (2001) 0.75
Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial). PLoS One (2017) 0.75
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1994) 25.02
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet (1999) 8.98
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet (1999) 5.00
Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90
Prospective assessment of mortality among a cohort of pregnant women in rural Malawi. Am J Trop Med Hyg (1996) 2.10
Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med (1992) 2.03
Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep (1985) 1.34
HIV, maternal death and child survival in Africa. AIDS (1996) 1.32
Prolonged lactation contributes to depletion of maternal energy reserves in Filipino women. J Nutr (1992) 1.22
Energy cost of physical activity throughout pregnancy and the first year postpartum in Dutch women with sedentary lifestyles. Am J Clin Nutr (1990) 1.18
Energy expenditure in human immunodeficiency virus infection. N Engl J Med (1997) 1.17
Prolactin and immunomodulation. Am J Med (1993) 1.14
Energy cost of lactation, and energy balances of well-nourished Dutch lactating women: reappraisal of the extra energy requirements of lactation. Am J Clin Nutr (1991) 1.09
Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr (1993) 1.05
Joint United Nations programme on HIV/AIDS (UNAIDS). HIV and infant feeding: an interim statement. Wkly Epidemiol Rec (1996) 1.02
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85
Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. JAMA (2001) 5.77
The right not to know HIV-test results. Lancet (1995) 5.16
Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol (1999) 3.88
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol (2000) 3.83
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53
Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis (2000) 3.02
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis (1998) 2.96
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88
The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis (2001) 2.79
Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet (1996) 2.76
Cot mattresses and sudden infant death syndrome. Lancet (1995) 2.60
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr (2000) 2.22
The importance of core groups in the epidemiology and control of HIV-1 infection. AIDS (1991) 2.21
Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol (1998) 2.21
Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02
Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med (1994) 2.01
The increasing frequency of heterosexually acquired AIDS in the United States, 1983-88. Am J Public Health (1990) 1.99
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol (2001) 1.95
The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis (1996) 1.88
Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS (2001) 1.88
Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis (1995) 1.86
Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Pediatr Infect Dis J (2001) 1.81
Role of sexually transmitted diseases in transmitting human immunodeficiency virus. Genitourin Med (1988) 1.78
Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis (1998) 1.74
Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis (1994) 1.70
Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis (1995) 1.62
Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol (1994) 1.60
Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis (2000) 1.56
Prevalence of Helicobacter pylori and endoscopic findings in HIV seropositive patients with upper gastrointestinal tract symptoms at Kenyatta National Hospital, Nairobi. East Afr Med J (2002) 1.55
HIV-1 testing in pregnancy: acceptability and correlates of return for test results. AIDS (2000) 1.53
Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (1998) 1.51
Syphilis control during pregnancy: effectiveness and sustainability of a decentralized program. Am J Public Health (2001) 1.51
Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis (2001) 1.50
No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate. AIDS Res Hum Retroviruses (2005) 1.47
Preparation for AIDS vaccine evaluation in Mombasa, Kenya: establishment of seronegative cohorts of commercial sex workers and trucking company employees. AIDS Res Hum Retroviruses (1994) 1.47
Decreased incidence of sexually transmitted diseases among trucking company workers in Kenya: results of a behavioural risk-reduction programme. AIDS (1997) 1.45
Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. Int J Gynecol Cancer (2003) 1.45
Combined trabeculectomy, cataract extraction, and foldable lens implantation. J Cataract Refract Surg (1992) 1.44
2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabet Med (2010) 1.42
A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils. J Immunol Methods (1990) 1.42
Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr (2001) 1.41
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
Predictors of multi-organ dysfunction in heatstroke. Emerg Med J (2005) 1.38
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. J Virol (1999) 1.37
Verbal autopsy: a tool for determining cause of death in a community. East Afr Med J (1990) 1.36
HIV testing men in the antenatal setting: understanding male non-disclosure. Int J STD AIDS (2009) 1.34
Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr (2000) 1.33
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Lett (1999) 1.32
Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis (1997) 1.29
Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.29
Phylogenetic evaluation of Kenyan HIV type 1 isolates. AIDS Res Hum Retroviruses (1997) 1.29
Cot mattress biodeterioration and SIDS. Lancet (1990) 1.29
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg (1985) 1.29
Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya. AIDS (1999) 1.27
Genital ulcer disease among STD clinic attenders in Nairobi: association with HIV-1 and circumcision status. Int J STD AIDS (1996) 1.26
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. AIDS Res Hum Retroviruses (2004) 1.25
Pattern of sexually transmitted diseases and risk factors among women attending an STD referral clinic in Nairobi, Kenya. Sex Transm Dis (2000) 1.24